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Tissue-specific expression  
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graft-versus-host Disease in the rat
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Isha A. Butt2, Jean Norden3, Ralf Dressel4, Anne M. Dickinson3 and Marit Inngjerdingen1,2*
1 Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway, 2 Department of 
Immunology, Oslo University Hospital – Rikshospitalet, Oslo, Norway, 3 Institute of Cellular Medicine, Medical School, 
Newcastle University, Newcastle-upon-Tyne, UK, 4 Institute of Cellular and Molecular Immunology, University Medical Center 
Göttingen, Göttingen, Germany
MicroRNAs (miRNA) have emerged as central regulators of diverse biological processes 
and contribute to driving pathology in several diseases. Acute graft-versus-host disease 
(aGvHD) represents a major complication after allogeneic hematopoietic stem cell trans-
plantation, caused by alloreactive donor T cells attacking host tissues leading to inflam-
mation and tissue destruction. Changes in miRNA expression patterns occur during 
aGvHD, and we hypothesized that we could identify miRNA signatures in target tissues 
of aGvHD that may potentially help understand the underlying molecular pathology of the 
disease. We utilized a rat model of aGvHD with transplantation of fully MHC-mismatched 
T cell depleted bone marrow, followed by infusion of donor T cells. The expression 
pattern of 423 rat miRNAs was investigated in skin, gut, and lung tissues and intestinal 
T  cells with the NanoString hybridization platform, in combination with validation by 
quantitative PCR. MHC-matched transplanted rats were included as controls. In the 
skin, upregulation of miR-34b and downregulation of miR-326 was observed, while in the 
intestines, we detected downregulation of miR-743b and a trend toward downregulation 
of miR-345-5p. Thus, tissue-specific expression patterns of miRNAs were observed. 
Neither miR-326 nor miR-743b has previously been associated with aGvHD. Moreover, 
we identified upregulation of miR-146a and miR-155 in skin tissue of rats suffering from 
aGvHD. Analysis of intestinal T cells indicated 23 miRNAs differentially regulated between 
aGvHD and controls. Two of these miRNAs were differentially expressed either in skin 
(miR-326) or in intestinal (miR-345-5p) tissue. Comparison of intestinal and peripheral 
blood T cells indicated common dysregulated expression of miR-99a, miR-223, miR-
326, and miR-345-5p. Analysis of predicted gene targets for these miRNAs indicated 
potential targeting of an inflammatory network both in skin and in the intestines that 
may further regulate inflammatory cytokine production. In conclusion, comprehensive 
miRNA profiling in rats suffering from aGvHD demonstrate tissue-specific differences in 
the expression patterns of miRNA that may not be detected by profiling of peripheral 
blood T cells alone. These tissue-specific miRNAs may contribute to distinct pathologic 
mechanisms and could represent potential targets for therapy.
Keywords: agvhD, T cells, skin, mirna, gut
Abbreviations: aGvHD, acute graft-versus-host disease; APC, antigen-presenting cells; IELs, intraepithelial lymphocytes; IPA, 
Ingenuity Pathway Analysis; TGF-β, transforming growth factor beta; Th, T helper; Treg, T regulatory cells.
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inTrODUcTiOn
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) 
is a treatment option for hematological malignancies or autoim-
mune disorders. Acute graft-versus-host disease (aGvHD) repre-
sents a major complication after allo-HSCT with high morbidity 
and mortality, next to other complications, such as relapse of 
the malignancy, engraftment failure, or opportunistic infections 
(1). GvHD is evoked by donor T cells present in the graft that 
recognize and attack mismatched host tissues in an immunosup-
pressed environment. Host antigen-presenting cells (APC) are 
activated as a consequence of damage to epithelial barriers and 
the ensuing inflammation that is triggered by the pretransplant 
conditioning. Donor T cells are activated by host APC in drain-
ing lymph nodes, enter the circulation, and extravasate into the 
gastrointestinal tract, skin, lung, and liver, representing major 
target tissues for aGvHD, where they mediate further increased 
inflammation and tissue damage (2).
Recent years have seen a surge of interest in the potential of 
microRNAs (miRNAs) as both biomarkers to predict GvHD devel-
opment and targets for therapeutic interventions (3–6).  miRNAs 
are small non-coding RNAs of 19–22 nucleotides in length that 
negatively influence protein expression by either degrading mes-
senger RNA (mRNA) or repressing its translation by binding to 
the 3'-untranslated region (7). miRNAs are potent regulators of 
biological processes and have been shown to play central roles in 
the regulation of immune responses (8). miRNAs only partially 
pair with their target mRNA, implying that a single miRNA can 
target several different mRNA molecules and a given mRNA can 
be targeted by several miRNAs (9). This infers that miRNAs are 
part of a complex regulatory network, potentially involving sev-
eral different miRNAs simultaneously. Several miRNAs have been 
identified as critical regulators of T-cell activity and hence have 
been associated with several cancers, autoimmune diseases, and 
GvHD (5). Particular miRNAs associated with aGvHD include 
miRNAs that enhance T-cell activation, such as miR-155 (4, 10), 
miR-142 (11), miR-29a, miR-29b, and the miR-17-92 cluster (12), 
and miRNAs that repress T-cell activation, such as mir-146a (13), 
which is also upregulated in T regulatory cells (Tregs) (14).
The expression patterns of miRNA change in response to 
external factors, and their expression patterns can be tissue and 
cell specific (15, 16). As aGvHD affects several distinct organs, 
we hypothesized that discrete miRNA signatures could be identi-
fied in different target tissues of aGvHD that may potentially 
help understand the underlying molecular pathology of the 
disease. We undertook a study to comprehensively analyze and 
compare the miRNA expression signature in three classical target 
tissues for aGvHD: skin, intestines, and lung. For this purpose, 
we obtained gut, skin, and lung tissues from rats suffering from 
aGvHD, as well as from T cells isolated from the intestines or 
peripheral blood and analyzed miRNA expression using the 
NanoString platform and quantitative real-time PCR (qRT-PCR). 
This study thus represents a systematic approach for profiling of 
differentially expressed miRNA in target tissues during aGvHD. 
We also identified a regulatory network of miRNAs and their 
predicted gene targets, consisting mainly of cytokines and their 
transcriptional regulators.
MaTerials anD MeThODs
animals and ethical considerations
Male rats aged 8- to 12-weeks of the strains PVG (RT1c, 
CD45.1), PVG.7B (RT1c, CD45.2), and the MHC congenic 
rat strain PVG.1N (RT1n, CD45.1) were used. The PVG.1N 
rat strain has the same genetic background as the PVG strain 
with the exception of the MHC complex that is from the Brown 
Norway rat. The rats have been maintained at the Department 
of Comparative Medicine, Institute of Basic Medical Sciences, 
University of Oslo, for more than 20 generations. The 
Department of Comparative Medicines institutional veterinar-
ian has established the rules for feeding, monitoring, handling, 
and sacrifice of animals in compliance with regulations set by 
the Ministry of Agriculture of Norway and “The European 
Convention for the Protection of Vertebrate Animals used for 
Experimental and other Scientific Purposes.” The institutional 
veterinarian has delegated authority from the Norwegian 
Animal Research Authority (NARA). The laboratory animal 
facilities are subject to a routine health-monitoring program 
and tested for infectious organisms according to a modifica-
tion of Federation of European Laboratory Animal Science 
Associations (FELASA) recommendations. The use of animals 
for this study was approved by NARA, license number 6013 
(in vitro) and 6060 (in vivo). Rats were sacrificed by asphyxi-
ation with CO2 in a chamber allowing controlled input of gas, 
such as to reduce suffering of the animals.
Bone Marrow Transplantation and 
induction of acute gvhD
Transplantation with 3 × 107 T-cell depleted bone marrow cells 
was performed with PVG.7B rats as donors and age-matched 
MHC-mismatched PVG.1N (n = 6) or MHC-matched PVG rats 
(n = 6) as recipients after irradiation at 8.5 Gy from a 137Cs source 
(Gammacell 3000 Elan, MDS Nordion, USA) under anesthesia 
with ZRF cocktail (3.3 mg Zolazepam, 3.3 mg Tiletamine, 0.5 mg 
Xylazine, and 2.6 μg Fentanyl per ml 0.9% NaCl; 1 ml/kg). Bone 
marrow was obtained by flushing the tibias and femurs with 
RPMI containing 2% FBS, followed by passage through 70 μm 
nylon cell strainer (BD Biosciences), and separation of mononu-
clear cells by density gradient centrifugation on Lymphoprep™ 
1.077A (Axis-Shield, Oslo, Norway). T cells were depleted with 
a combination of anti-CD5 (OX19, mIgG1) and anti-TCRαβ 
(R73, mIgG1) antibodies and anti-mouse IgG coated Dynabeads 
(Thermo Fisher Scientific, Waltham, MA, USA). The number of 
CD3+ T cells was reduced more than 10-fold, from 3.0 to 0.2% 
as assessed by flow cytometry. To induce acute GvHD, 1 × 107 
cervical and mesenteric lymph node cells (~60% CD3+NKR-
P1A− T cells as evaluated by flow cytometry) from PVG.7B rats 
were infused into recipients 14 days post transplantation. Weight 
and GvHD symptoms (activity, kyphosis, skin, and fur integrity) 
were assessed twice weekly. Rats with severe weight loss (>15%) 
or evident signs of disease (severe skin lesions) were sacrificed 
12–14  days after T-cell infusion. Scoring was performed non-
blinded. In this model, most severe pathology is observed in the 
skin and oral mucosae.
TaBle 1 | list of primers for mrna expression analysis.
gene Primer sequence 5′–3′ accession iD
B2m F: GAGCAGGTTGCTCCACAGGT NM_012512.2
R: CAAGCTTTGAGTGCAAGAGATTGA
Ccl5 F: CTTGCAGTCGTCTTTGTCACTC NM_031116.3
R: CACTTCTTCTCTGGGTTGGCA
Ccl22 F: TGCTTCAGACTTCCTTGGCC NM_057203.1
R: GTGCTGGAGACCGAGAAACA
Cxcl10 F: TGCAAGTCTATCCTGTCCGC NM_139089.1
R: ACGGAGCTCTTTTTGACCTTC
Cxcl11 F: CGGTTCCAGGCTTCGTTATG NM_182952.2
R: CTTGCTTGGATGTGGGGTCC
Ets1 F: ACGACTACCCTTCCGTCATTC NM_012555.2
R: CGGTCACAACTATCGTAGCTCT
Gapdh F: GGGCTGCCTTCTCTTCTGAC NM_017008.3
R: CGCCAGTAGACTCCACGACA
Hdac1 F: CTCCATCTTCTCTCCAAGTCCCT NM_001025409.1
R: GTGCGCTGGTCCCTATCTAGT
Hdac3 F: CTGGGAGGTGGTGGTTACAC NM_053448.1
R: TCTGATTCTCGATGCGGGTG
IL10 F: CCTCTGGATACAGCTGCGAC NM_012854.2
R: TAGACACCTTTGTCTTGGAGCTTA
IL18 F: ACCTGAAGATAATGGAGACTTGG NM_019165.1
R: TCTGGTCTGGGATTCGTTGG
IL22 F: TCCAGCAGCCATACATCGTC NM_001191988.1
R: GACTGGGGGAGCAGAACATC
Il6r F: CTATACCCCTGCCCACATTCC NM_017020.3
R: GACTTCCATTTCTTCTTGAGTCTC
Notch1 F: TCAGCTCCCTGCAAGAATGG NM_001105721.1
R: ATCGATGCCTCGCTTCTGTG
Snai1 F: AGCAGAGTTGTCTACCGACC NM_053805.1
R: GGAAGGTGAACTCCACACAC
Tgfb F: AGGGCTACCATGCCAACTTC NM_021578.2
R: CCACGTAGTAGACGATGGGC
Tgfbr2 F: AGCTCTAACATCCTAGTAAGAAGCG NM_031132.3
R: GTATCTCGCTGTTCCCACCTG
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isolation of Tissues and T cells
Immediately after sacrifice, tissue samples of small intestines, liver, 
lung, and skin were dissected and stored in RNAlater® (Thermo 
Fisher Scientific) at −80°C until further processing. Peripheral 
blood mononuclear cells (PBMCs) were prepared from heparin-
ized peripheral blood by Lymphoprep™ separation (Axis-Shield, 
Oslo, Norway). Intraepithelial lymphocytes (IELs) from the small 
intestine were isolated as previously described (17). T cells were 
enriched from PBMCs or IELs by positive immunomagnetic 
selection with Dynabeads® Pan Mouse IgG (Thermo Fisher 
Scientific) coated with anti-rat TCRαβ antibodies (clone R73, 
mIgG1). T cells were extensively washed in PBS, pelleted, added 
RNAlater®, and stored at −80°C until further use (>6 months).
rna extraction, cDna synthesis, and 
Quantitative real-Time Pcr
Total RNA was extracted from skin, lung, intestinal, or liver tis-
sue, or from intestinal or peripheral blood T cells isolated from 
control animals (n =  6) or aGvHD animals (n =  6) using the 
miRVana miRNA Isolation Kit (Ambion, Austin, TX, USA). 
Tissue RNA was also isolated with TRI reagent (Ambion, 
Thermo Fisher Scientific), in accordance with the manufacturer’s 
instructions and using RNase-free equipment. For RNA assessed 
by NanoString, RNA concentration and RNA integrity number 
(RIN) were measured using the Bioanalyzer 2100 and RNA 6000 
Nano Kit (Agilent Technologies), and only samples with RIN 
values ≥7 were included. For RNA isolated by TRI reagent, purity 
and concentration was measured by 260:280 and 260:230 ratios 
(purity measured between 1.8 and 2.0) using NanoDrop 1000 
spectrophotometer (Thermo Fisher Scientific), and the integrity 
was assessed by gel electrophoresis.
For miRNA expression analysis, 10  ng of total RNA was 
reverse transcribed using the TaqMan® MicroRNA Reverse 
Transcription Kit (Applied Biosystems) and specific TaqMan® 
MicroRNA/Endogenous Control RT Assay for 4.5S RNA (H) 
A, 4.5S RNA (H) B, snoRNA, U87, miR-19b, miR-20a, miR-21, 
miR-22, miR-29a, miR-29b, miR-30b-5p, miR-34b, miR-99a, 
miR-142-5p, miR-146a, miR-155, miR-223, miR-326, miR-
344a, miR-345-5p, miR-466b, miR-542-5p, miR743b, miR-874, 
and miR-3573. qRT-PCR was performed using the SensiFAST 
probe Hi-ROX kit (Bioline) and specific TaqMan® MicroRNA/
Endogenous Control TM Assays in a total volume of 10 μl/reac-
tion [5 μl SensiFAST Bioline probe Hi-ROX mix, 0.5 μl Taqman 
(TM) assay, 1.5 μl ddH2O, and 3 μl (3 ng) of cDNA], and cycling 
conditions comprised 10 min at 95°C and then 40 cycles at 95°C 
(15 s) and 60°C (1 min). miRNA expression levels were normal-
ized with respect to the endogenous controls and expression 
levels reported as log of 2−ΔΔCt.
To generate cDNA for mRNA expression studies, 1  μg 
of RNA was mixed with 2  μl of random hexamer primers 
(Promega, Madison, WI, USA) and ddH2O up to a volume of 
15 μl, and run for 10 min at 70°C. One microliter of M-MLV 
reverse transcriptase, 5  μl of M-MLV buffer, 1  μl of RNAsin 
(all from Promega, Madison, WI, USA), 0.01M of DTT (1 μl, 
Sigma-Aldrich), and 2 μl of 10 mM dNTPs were then added to a 
total volume of 25 μl and run for 1 h at 37°C. cDNA was stored 
at −20°C until use. Real-time PCR was performed with Power 
SYBR® Green PCR Master Mix (Applied Biosystem, Waltham, 
MA, USA) using 7900HT Fast Real-Time PCR System (Life 
Technologies, Waltham, MA, USA) and initially run for 2 min at 
50°C and 10 min at 95°C, followed by 40 cycles of denaturation 
at 95°C (15 s) and amplification at 60°C (1 min). Melting curve 
analysis was performed at 95°C (15 s) followed by 60°C (20 s) 
and 95°C (20 s). Primers were designed using NCBI PrimerBlast, 
and specificity was tested in silico by BLAST or MFEprimer-2.0. 
Primers are listed in Table  1. mRNA expression levels were 
normalized with respect to β-2-microglobulin (B2m). B2m was 
chosen as the preferred reference gene due to its stable expres-
sion across tissues and between aGvHD and control samples 
compared to another tested reference gene Gapdh, using the 
algorithm NormFinder.1 Expression levels were reported as log 
of 2−ΔΔCt.
1 www.moma.dk/normfinder-software
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mirna expression analysis by nanostring 
ncounter system mirna assay
Expression levels of 423 different miRNAs were measured 
using the nCounter® Rat v1.5 miRNA Expression Assay Kit 
from NanoString Technologies, Seattle, WA, USA. In this assay, 
 miRNAs are detected and counted by hybridization with fluores-
cently labeled barcoded probes, followed by scanning and expres-
sion quantification. The assay incorporates 423 mature miRNAs 
based on miRBase version 17 and includes 6 positive mRNA 
controls, 8 negative mRNA controls, 3 ligation positive, 3 ligation 
negative synthetic miRNA controls, and 4 mRNA housekeeping 
controls (Act6, B2m, Gapdh, and Rpl19). As starting material 
100 ng of RNA from T cells and 150 ng of RNA from tissues were 
used. Three control rats and three aGvHD rats were used for 
the analysis. Data normalization was performed using nSolver 
Analysis Software v2.5 (NanoString Technologies) incorporating 
positive and negative background subtraction based on geometric 
means and codeset content normalization to housekeeper genes 
established using geometric means. After normalization, one 
aGvHD gut sample and one control skin sample were excluded 
from further analysis due to quality control issues with content 
normalization.
ingenuity Pathway analysis
To explore possible interactions between miRNAs and their 
putative gene targets, pathway analysis was performed using 
the QIAGEN Ingenuity Pathway Analysis (IPA) software 
(Ingenuity Systems, Redwood City, CA, USA). Pathway analysis 
was restricted to predicted targets, both direct and indirect, 
of validated dysregulated miRNAs. miRNA target prediction 
analyses were filtered for genes involved in T cell activation, T 
cell migration, T cell proliferation, and GvHD and other inflam-
matory pathways. Based on these inputs, a regulatory network 
was built around the dysregulated miRNAs in skin or gut, in order 
to identify potential gene targets.
statistical analysis
Quantitative PCR data were analyzed using GraphPad Prism 
5 (La Jolla, CA, USA). The difference between two groups was 
examined using the Student’s t-test (two-tailed) with Welch’s 
correction. NanoString data analysis for fold change expression 
differences between two groups was calculated using nSolver 
v2.5 (NanoString Technologies) based on normalized ratio data. 
Further analysis was performed using a pipeline designed by 
Newcastle University, Hematological Sciences Department, to 
integrate a number of “R” statistical packages in the “R” program-
ming language, which are publically available via Bioconductor.2 
p values between two groups were generated using a two-tailed 
t-test. Volcano plots were generated using functions within the 
“ggplot2” package, and heatmaps were constructed using “gplots” 
and “RColorBrewer,” based on an unsupervised clustering 
approach with a Euclidean distance measure and “Complete” as 
the agglomeration method.
2 www.bioconductor.org 
resUlTs
mir-326 and mir-34b are Dysregulated in 
skin and May Potentially Target notch1 
and inflammatory cytokine genes
Acute GvHD was induced in rats by transplanting T-cell-depleted 
bone marrow from PVG.7B strain donors (RT1c, CD45.2 allotype) 
to irradiated MHC-mismatched PVG.1N strain recipients (RT1n, 
CD45.1 allotype), followed 14 days later by infusion of donor T 
cells from PVG.7B. As controls, irradiated PVG (RT1c, CD45.1 
allotype) recipients were transplanted with MHC-matched 
PVG.7B T-cell depleted bone marrow and infused with donor 
T cells at day 14. No symptoms of aGvHD developed in these 
animals, but using the same protocol ensured that differential 
expression of miRNAs would specifically be due to aGvHD 
responses. With this protocol, rats started showing symptoms of 
aGvHD around day 12 after DLI and worsened rapidly as observed 
by rapidly progressing weight loss (Figure S1 in Supplementary 
Material), ruffled fur, skin lesions, and kyphosis. Rats with the 
strongest symptoms had severe leukopenia in the spleen. Total 
RNA was isolated from gut, skin, liver, and lung tissues from rats 
with aGvHD or from control rats. To obtain miRNA expression 
signatures in these target organs of aGvHD, expression of 423 rat 
miRNAs were tested using the nCounter® NanoString hybridiza-
tion platform.
Assessment of normalized expression data for all miRNAs in 
skin samples obtained from both aGvHD and control rats showed 
significant differential expression of three miRNAs, with upregu-
lation of miR-34b (2.7-fold change, p = 0.013) and miR-3596d 
(2.4-fold change, p =  0.006) and downregulation of miR-326 
(−2.6-fold change, p = 0.009) in aGvHD samples (Figures 1A,B). 
Further validation by qRT-PCR analysis of skin samples obtained 
from the same and another independent transplantation experi-
ment showed trends toward increased expression of miR-34b and 
decreased expression of miR-326 (Figure 1C). Unavailability of 
a TaqMan probe against rno-mir-3596d prevented its validation.
We searched for predicted gene targets for miR-326 and miR-
34b using QIAGEN’s IPA software. We filtered for genes involved 
in T cell activation and GvHD responses to narrow down the list 
of predicted targets. To assess how these predicted targets could 
interact, we performed an IPA pathway analysis. This analysis 
demonstrated that both miR-326 and miR-34b may converge on 
at least two gene targets, Notch1 and Snai1 (Figure 2A), although 
these genes were not differentially expressed in skin tissues from 
aGvHD rats compared to controls (Figure  2B). miR-326 may 
additionally regulate the histone deacetylase 3 (Hdac3) gene. 
While Hdac3 was not differentially expressed, the closely related 
Hdac1 gene was over-expressed in skin tissues from aGvHD rats 
compared to controls (Figure 2B). In addition, several cytokines 
and cytokine receptors were indirectly linked to these miRNAs 
and their potential primary targets. Quantitative RT-PCR expres-
sion analyses showed significant upregulation in aGvHD rats of 
Ccl5, Ccl22, Cxcl11, Il6r, and Tgfbr2, and a trend toward upregu-
lation of Il10, Il18, and Tgfb (Figure 2B). In addition, we detected 
upregulation of another predicted target gene for miR-326, the 
transcription factor Ets1 (Figure 2B).
FigUre 1 | mirna expression signature in skin during agvhD. (a) 
Volcano plot showing the relationship between fold change and significance 
between the two groups. The horizontal dashed line indicates cutoff for 
significance p < 0.05 (−log10 p-value >1.3) and the vertical lines for fold 
change ≥1.5/≤−1.5. (B) Heatmap showing unsupervised hierarchical 
clustering of differentially expressed miRNAs in skin between control (n = 2) 
and aGvHD (n = 3) animals. Each column represents an individual rat. 
Relative fold change is indicated by the color scale (red: high; blue: low). (c) 
qRT-PCR analysis of miR-34b and miR-326 expression in skin of control 
(n = 6) or aGvHD (n = 6) rats. Samples were normalized to endogenous 
controls and expression levels reported as log of 2−ΔΔCt ± SD. Significance 
was calculated using the Student’s t-test (two-tailed) with Welch’s correction.
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mirna expression Profiling in the lung
In our rat model of aGvHD, the lungs appear macroscopically 
normal during aGvHD. However, we have previously detected 
increased expression of IFN-γ in the lungs during aGvHD, sug-
gesting that lungs are affected3. miRNA expression profiling of 
lung tissues demonstrated differential expression of seven miR-
NAs, with downregulation of miR-344a-3p (−2.36-fold change) 
and upregulation of miR-103 (4.04-fold change), miR-22 (2.72-
fold change), miR-30b-5p (1.51-fold change), miR-347 (1.95-fold 
change), miR-382 (2.82-fold change), and miR-3573-3p (3.32-
fold change) (Figures 3A,B). Quantitative RT-PCR validation of 
three upregulated miRNAs with low p-values and the one down-
regulated miRNA did not confirm the differential expression in 
aGvHD samples over controls (Figure 3C). The mild pathology 
observed in lung may imply that putative differences between 
aGvHD and control rats may be too low to be detected regularly.
Differential expression of  
mir-146a and mir-155 in skin
Upregulation or downregulation of miRNAs previously impli-
cated in aGvHD pathogenesis such as the miR-17-92 cluster, miR-
29a, miR-29b, miR-146a, or miR-155 did not reach significance in 
the NanoString analysis. However, several of these miRNAs were 
detected as differentially expressed below the threshold cutoff of 
p < 0.05 (data not shown). We therefore tested their expression in 
tissues by qRT-PCR. In this analysis, we also included liver, which 
is another target tissue for aGvHD. We found clear upregulation 
of miR-146a and miR-155, but not of miR-29a, miR-29b, miR-
19b, or miR-20a in skin (Figure 4A and data not shown). None 
of the tested miRNAs were significantly differentially expressed 
in liver (Figure 4B), lung (Figure 4C), or gut tissues (Figure 4D).
The mirna expression Pattern of 
intestinal T cells is More similar to Blood 
T cells than to intestinal Tissue
In the small intestine, eight miRNAs were differentially expressed 
in aGvHD rats compared to controls. Specifically, upregulation of 
miR-466b (1.99-fold change, p = 0.017), miR-542-5p (3.09-fold 
change, p = 0.020), miR-568 (2.14-fold change, p = 0.020), miR-
3580-3p (1.99-fold change, p = 0.017), miR-3581 (1.79-fold change, 
p = 0.019), and miR-3597-5p (1.9-fold change, p = 0.037), and 
downregulation of miR-345-5p (−1.56-fold change, p =  0.006) 
and miR-743b (−2.74-fold change, p  =  0.031) were detected 
for aGvHD samples compared to controls (Figures  5A,B). 
Quantitative RT-PCR validation of samples obtained from the 
same and another independent transplantation experiment 
confirmed downregulation of miR-743b (Figure 5C). There was 
also a trend toward downregulation of miR-345-5p (p = 0.140), 
although not to significance (Figure  5C). The upregulation of 
miR-542-5p or miR-466b was not confirmed in the validation 
samples (Figure 5C and data not shown).
In order to specifically address changes in miRNA profiles 
in T cells from target tissues, we profiled miRNA expression in 
3 Boieri et al. (unpublished observation).
FigUre 2 | Prediction of mrna targets by ingenuity Pathway analysis. (a) A network of possible mRNA targets and affected biological pathways for 
miR-34b and miR-326 was constructed using QIAGEN’s IPA software. Dashed lines represent indirect interactions, while solid lines indicate direct interactions. (B) 
mRNA expression analysis by qRT-PCR analysis in skin samples from controls (n = 6) or aGvHD rats (n = 6). Samples were normalized to an endogenous control 
(B2m) and expression levels reported as log of 2−ΔΔCt ± SD. Significance was calculated using the Student’s t-test (two-tailed) with Welch’s correction.
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FigUre 3 | mirna expression signature in lung during agvhD.  
 
(a) Volcano plot showing the relationship between fold change and 
significance between the two groups. The horizontal dashed line indicates 
cutoff for significance p < 0.05 (−log10 p-value >1.3) and the vertical lines for 
fold change ≥1.5/≤−1.5. (B) Heatmap showing unsupervised hierarchical 
clustering of differentially expressed miRNAs in lung between control (n = 3) 
and aGvHD (n = 3) animals. Each column represents an individual rat. 
Relative fold change is indicated by the color scale (red: high; blue: low). (c) 
qRT-PCR analysis of miRNA expression in lung of control (n = 6) or aGvHD 
(n = 6) rats. Samples were normalized to endogenous controls and 
expression levels reported as log of 2−ΔΔCt ± SD. Significance was calculated 
using the Student’s t-test (two-tailed) with Welch’s correction.
(Continued)
FigUre 3 | continued
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TCRαβ+ T cells purified from the IEL compartment. Although 
aGvHD in this rat model likely affects the skin more than any 
other tissue, we chose to purify T cells from the intestines due to 
the technical difficulty in purifying high enough T cell numbers 
from the skin. Total RNA from intestinal T cells was subjected 
to NanoString analysis as above with samples obtained from rats 
suffering from aGvHD (n = 3) or from control rats (n = 3). Here, 
17 miRNAs were downregulated and 5 miRNAs were upregulated 
(fold change >1.3, p <  0.05, Table  2) in animals with aGvHD 
compared to controls (Figures 6A,B). In particular, downregula-
tion of miR-874 (−2.89-fold change, p = 0.002), mir-20b (−3.37-
fold change, p = 0.005), miR-330 (−4.11-fold change, p = 0.006), 
and miR-326 (−2.22-fold change, p = 0.008), and upregulation of 
miR-3545-5p (1.97-fold change, p = 0.006), miR-3548 (2.59-fold 
change, p =  0.006), and miR-21 (3.52-fold change, p =  0.017) 
was observed. Validation by qRT-PCR analysis of miR-874 
from another independent experiment showed a trend toward 
downregulation in intestinal T cells, while miR-21 was not 
differentially expressed (Figure  6C). Moreover, we found that 
miR-99a, miR-326, and miR-345-5p, which were all indicated as 
downregulated by NanoString were detected as upregulated by 
qRT-PCR (Figure 6C). We also observed upregulation of miR-223 
in intestinal T cells (Figure 6C). When compared to T cells from 
peripheral blood, qRT-PCR analyses of purified TCRαβ+ blood 
T cells from the same rats indicated a similar expression pattern, 
with upregulation of miR-21, miR-99a, miR-223, miR-326, and 
miR-345-5p (Figure 6D), indicating that the GvHD grade during 
sampling of T cells may be crucial in terms of miRNA expression. 
We next sought to identify miRNAs commonly dysregulated in 
both intestinal tissue and purified intestinal T cells, based on the 
data obtained from NanoString analysis. Here, miR-125a-5p, 
miR-326, miR-345-5p, and miR-743b were downregulated in 
both intestinal tissue and intestinal T cells, while miR-17-1-3p, 
miR-290, and miR-3548 were upregulated (Figure 6E). Lastly, a 
comparison of intestinal tissue with intestinal T cells from aGvHD 
rats showed that only miR-743b were significantly differentially 
expressed (Figure 6F).
We next performed pathway analysis of the miRNAs found sig-
nificantly upregulated by qPCR analysis in intestinal tissue and/or 
intestinal T cells in order to analyze whether and how these miRNAs 
interact with each other. As input for the analysis, we chose miR-21, 
miR-99a, miR-223, miR-326, miR-345-5p, and miR-743b, and also 
genes involved in GvHD pathogenesis as well as T cell activation, 
proliferation, and migration. The generated network depicted in 
FigUre 4 | Upregulation of mir-146a and mir-155 in skin but not liver, lung, and intestines during agvhD. qRT-PCR analysis of miRNA expression in (a) 
skin (controls, n = 6; aGvHD, n = 6), (B) liver (controls, n = 6; aGvHD, n = 6), (c) lung (controls, n = 6; aGvHD, n = 6), or (D) intestines (controls, n = 6; aGvHD, 
n = 6). Samples were normalized to endogenous controls and expression levels reported as log of 2−ΔΔCt ± SD. Significance was calculated using the Student’s 
t-test (two-tailed) with Welch’s correction.
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Figure 7A demonstrates that miR-21, miR-223, and miR-326 may 
all interact in the same network of molecular responses related to T 
cell activation and migration. miR-99a, miR-345-5p, or miR-743b 
was not found associated with any of the other miRNAs or to genes 
related to T cell activation. qPCR expression analysis of intestinal T 
cells showed upregulation of the inflammatory chemokine Cxcl10, 
identified in the network, and downregulation of Il22 expression 
(Figure  7B). In intestinal tissues, increased expression of Ccl5 
and a tendency toward increased expression of Il18 was detected 
in aGvHD rats, similarly to the skin. As for the skin, major hubs 
represented by Notch1, Hdac3, and Snai1 were identified, but none 
of these genes were found to be differentially expressed in intestinal 
tissues from aGvHD rats (Figure 7C).
DiscUssiOn
MicroRNAs are now considered central regulators of gene 
expression, and miRNA expression is tightly linked to different 
cellular responses and may be predictive of underlying molecu-
lar mechanisms in complex diseases such as aGvHD. Using a rat 
model of aGvHD, we comprehensively analyzed and compared 
the miRNA expression profiles in aGvHD target tissues and in 
T cells isolated from intestines or blood. As miRNA may be 
variably expressed in distinct tissues, and between species, the 
contribution from our rat model may be important for evaluat-
ing miRNAs that are central regulators of GvHD pathology. We 
also identified genes that may be targeted by one or more of 
the miRNAs differentially expressed during aGvHD in the rat, 
although these results does not make firm inferences. Further 
direct functional tests such as luciferase assays are required 
to identify the interaction between a specific miRNA and its 
target gene.
Although alloreactive T cells infiltrate target tissues and are 
the direct cause of tissue destruction, there was little overlap of 
differentially expressed miRNAs in skin, intestinal, and lung tis-
sues as a consequence of aGvHD. Macroscopically, the skin and 
TaBle 2 | Differentially expressed mirna in Tcrαβ+ T cells from the iel 
compartment.
gene accession iD Fold change p-value
Rno-miR-874 MIMAT0005284 −2.89 0.002
Rno-miR-20b-3p MIMAT0003212 −3.37 0.005
Rno-miR-330 MIMAT0004641 −4.11 0.006
Rno-miR-3545-5p MIMAT0017799 1.97 0.006
Rno-miR-3548 MIMAT0017806 2.59 0.006
Rno-miR-326 MIMAT0000560 −2.22 0.008
Rno-miR-99b MIMAT0000821 −1.85 0.009
Rno-miR-702-3p MIMAT0017885 −2.75 0.011
Rno-let-7b MIMAT0000775 −1.95 0.012
Rno-miR-21 MIMAT0000790 3.52 0.017
Rno-miR-100 MIMAT0000822 −2.47 0.021
Rno-miR-181a MIMAT0000858 −1.80 0.027
Rno-miR-345-5p MIMAT0000594 −1.99 0.029
Rno-miR-125a-5p MIMAT0000829 −2.52 0.031
Rno-miR-99a MIMAT0000820 −1.96 0.037
Rno-miR-205 MIMAT0000878 −9.01 0.040
Rno-miR-351 MIMAT0000608 −2.92 0.042
Rno-miR-145 MIMAT0000851 −1.69 0.042
Rno-miR-10a-5p MIMAT0000782 −1.87 0.043
Rno-miR-384-3p MIMAT0005310 2.44 0.045
Rno-miR-876 MIMAT0012843 1.67 0.047
Rno-miR-674-3p MIMAT0005330 −1.98 0.049
FigUre 5 | mirna expression signature in small intestines during 
agvhD.  
 
(a) Volcano plot showing the relationship between fold change and 
significance between the two groups. The horizontal dashed line indicates 
cutoff for significance p < 0.05 (−log10 p-value >1.3) and the vertical lines for 
fold change ≥1.5/≤−1.5. (B) Heatmap showing unsupervised hierarchical 
clustering of differentially expressed miRNAs in gut between control (n = 3) 
and aGvHD (n = 2) animals. Each column represents an individual rat. 
Relative fold change is indicated by the color scale (red: high; blue: low). (c) 
qRT-PCR analysis of miRNA expression in small intestines of control (n = 6) 
or aGvHD (n = 6) rats. Samples were normalized to endogenous controls 
and expression levels reported as log of 2−ΔΔCt ± SD. Significance was 
calculated using the Student’s t-test (two-tailed) with Welch’s correction.
(Continued)
FigUre 5 | continued
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the oral mucosae are the most affected tissues in our rat model 
of aGvHD, with clear bruising and lesions. While the intestines, 
lung, and liver appear macroscopically less affected, we observe 
infiltration of donor T cells to the intestines and upregulation of 
IFN-γ in all tissues indicating that these tissues are targeted by 
the disease (Boieri et al., unpublished observation). In the skin, 
NanoString analysis indicated differential expression of miR-34b 
and miR-326 in rats with aGvHD compared to controls, although 
only a trend was observed by qRT-PCR. The miR-34 family was 
recently shown to be upregulated in the gut of patients during 
severe aGvHD (18). We did not detect differential expression of 
miR-34b or miR-326 in intestinal tissues of rats, and this may 
reflect the more severe pathology that is observed in skin rather 
than intestines of rats but also differences in tissue pathology. 
Rather in intestines, we detected significant downregulation 
of miR-743b in rats with aGvHD disease and a trend toward 
decreased expression of miR-345-5p. MiR-743b has not previ-
ously been associated with aGvHD or with any immune-related 
functions and thus represents an interesting miRNA for further 
investigations into its role in aGvHD pathology. Also, miR-326 
has not previously been implicated in aGvHD in any species. It 
FigUre 6 | mirna expression in intestinal T cells and comparison to intestinal tissues. (a) Volcano plot showing the relationship between fold change and 
significance between the two groups. The horizontal dashed line indicates cutoff for significance p < 0.05 (−log10 p-value >1.3) and the vertical lines for fold change 
≥1.5/≤−1.5. (B) Heatmap showing unsupervised hierarchical clustering of differentially expressed miRNAs in intestinal T cells between control (n = 3) and aGvHD 
(n = 3) animals. Each column represents an individual rat. Relative fold change is indicated by the color scale (red: high; blue: low). (c) qRT-PCR analysis of miRNA 
expression in intestinal T cells from control (n = 3) or aGvHD (n = 3) rats. Samples were normalized to endogenous controls and expression levels reported as log of 
2−ΔΔCt ± SD. Significance was calculated using the Student’s t-test (two-tailed) with Welch’s correction. (D) qRT-PCR analysis of miRNA expression in peripheral 
blood T cells from control (n = 3) or aGvHD (n = 3) rats. Samples were normalized to endogenous controls and expression levels reported as log of 2−ΔΔCt ± SD. 
Significance was calculated using the Student’s t-test (two-tailed) with Welch’s correction. (e) Volcano plot (left panel) and heatmap (right panel) showing differentially 
expressed miRNAs in intestinal T cells (C) and intestinal tissue (T) from aGvHD rats compared to intestinal T cells (C) and intestinal tissue (T) from controls. (F) 
Volcano plot showing the relationship between fold change and significance between the intestinal tissue and intestinal T cells from aGvHD rats. The horizontal 
dashed line indicates cutoff for significance p < 0.05 (−log10 p-value >1.3) and the vertical lines for fold change ≥1.5/≤−1.5.
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FigUre 7 | iPa network analysis of differentially expressed mirnas in intestinal tissue and T cells. (a) A network of possible mRNA targets and affected 
biological pathways for miR-21, miR-223, and miR326 was constructed using QIAGEN’s IPA software. Dashed lines represent indirect interactions, while solid lines 
indicate direct interactions. (B,c) mRNA expression analysis by qRT-PCR analysis of (B) intestinal T cells from controls (n = 3) or aGvHD rats (n = 3) or (c) intestinal 
tissue from controls (n = 6) or aGvHD rats (n = 6). Samples were normalized to endogenous control (B2m) and expression levels reported as log of 2−ΔΔCt ± SD. 
Significance was calculated using the Student’s t-test (two-tailed) with Welch’s correction.
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has, however, been implicated in immune-related disorders and 
is upregulated during the relapsing phase of multiple sclerosis, 
possibly contributing to T helper (Th) 17 differentiation (19, 20). 
We also detected differential expression of miR-326 in intestinal 
and blood T cells but not in intestinal tissues. As we were unable 
to purify high enough numbers of skin T cells, it is presently 
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unknown whether the differentially expressed miR-326 stems 
from the infiltrating alloreactive T cells or from other immune or 
non-immune cells in the skin tissue.
Ingenuity Pathway Analysis, which incorporates existing data 
on genes regulated by miRNAs from the literature, indicated 
that both miR-34b and miR-326 may share at least two target 
genes, Notch1 and Snai1 (21–24). Snail proteins are zinc-finger 
transcription factors classically associated with epithelia to 
mesenchymal transition (25). However, Snail proteins may also 
regulate immune responses, and a recent study indicated that 
Snail-expressing keratinocytes may induce production of pro-
inflammatory cytokines in response to TGF-β (26). This could 
correlate with the observed increased inflammatory cytokine 
expression levels in the skin, although Snai1 was not differen-
tially expressed in our analysis. Target prediction and pathway 
analysis identified Notch1 as a possible target in the network 
of differentially expressed miRNAs and genes in both skin and 
intestinal T cells, where it is potentially targeted by both miR-21 
and miR-326. Apart from its role in T cell development in the 
thymus, Notch1-dependent signaling in peripheral T cells may 
lead to increased production of inflammatory cytokines (27). 
Its role in regulating peripheral T cell activation and in driving 
differentiation of T helper subsets is still incompletely defined 
and likely context dependent. Notch1 signaling is suggested to 
contribute to both generation of Tregs (28) and Th1 cells (29). 
We have previously observed increased frequencies of Tregs 
in skin of rats with severe aGvHD (Boieri et  al., unpublished 
observation). In gliomas, miR-326 has been shown to partici-
pate in a feedback loop with Notch, where miR-326 expression 
is specifically repressed by Notch (22). We could not detect 
differential expression of Notch1 or Snail in rats with aGvHD. 
However, this might indicate that the mRNA expression of these 
genes is counter regulated to normal levels by miRNAs. This 
pathway could certainly be interesting to study in more detail 
in the future.
The miR-17-92 cluster, miR-146a, and miR-155 have been 
previously implicated in aGvHD, where they are shown to regu-
late different aspects of T cell allo-activation (4, 10, 12, 13, 30) or 
T helper cell differentiation (31). These miRNAs were not among 
the significantly differentially expressed miRNAs as detected 
by the NanoString analyses, but we clearly observed higher 
expression levels of miR-146a and miR-155 in skin tissue, but 
not in intestines, liver, and lung, by qRT-PCR. Both miR-17 and 
miR-19, as representatives of the miR-17-92 cluster, were tested 
in all tissues, but no changes were observed between controls and 
aGvHD rats (data not shown). The expression of miR-146a and 
miR-155 is induced by lipopolysaccharide, which in the context 
of aGvHD is released as a consequence of breached epithelial bar-
riers during pretransplantation irradiation. miR-155 is involved 
in a number of inflammatory responses, and its expression is 
induced by inflammatory cytokines. Importantly, miR-155 is 
shown to repress Socs1 expression leading to increased proin-
flammatory cytokine production (32), which could correlate 
with the higher expression levels of inflammatory cytokines in 
skin observed in this study. miR-146a is shown to target Traf6 
and Irak and thereby negatively regulate cytokine signaling and 
activation of the transcription factor NF-κB (33). miR-146a is 
also suggested to regulate differentiation of Th1 cells and more 
recently to critically control Treg functions through direct target-
ing of STAT1 (14).
We obtained discrepant results on the expression of miRNAs 
in intestinal T cells when comparing NanoString results with 
qRT-PCR analysis. Although the same miRNAs were detected 
as differentially expressed, miRNAs observed as downregu-
lated by NanoString were upregulated in cells when validated 
by qRT-PCR. Although great care was taken in sampling cells 
and tissues at the same severe stage of the disease, we cannot 
exclude differences in the stage of the disease at the time of 
sampling. We have previously observed that the composition 
of intestinal T cells may vary from rat to rat within the same 
strain and also that the T cell responses in the gut may vary 
between experiments and between rats within the same experi-
ment. In contrast, T cell markers and responses are stable in 
lymphatic tissues and in the skin (Boieri et  al., unpublished 
observation). It could be that initially downregulated miRNAs 
are upregulated as a compensatory feedback mechanism at 
late-stage aGvHD responses or vice  versa. Interestingly, we 
detected reduced expression of Il22 in T cells from the intes-
tine. IL-22 is shown to contribute to the severity of aGvHD 
pathogenesis, being produced by both innate and adaptive 
immune cells present in intestinal or skin tissues (34, 35). The 
observed reduction in Il22 expression in T cells isolated from 
rats with severe aGvHD could potentially represent a response 
to negative feedback mechanisms operating at the height of the 
proinflammatory responses. Whether the Il22 gene is regulated 
by a specific miRNA in the intestines of rats with aGvHD dis-
ease is currently unknown.
It appears from our data that tissue-specific expression 
patterns of miRNAs exist, with little overlap between tissues. 
This may be surprising, due to the fact that these tissues 
are infiltrated by alloreactive donor T cells during aGvHD. 
However, resident cells in tissues are affected by the disease 
and also other immune cells are recruited to the inflamed 
tissues. Our analysis encompassed the whole tissue, and 
no distinctions were made on the contributions from dif-
ferent cell types, immune or non-immune. It could be that 
the majority of dysregulated miRNA expression patterns in 
tissues are due to infiltrating T cells, but the unique cellular 
composition of different tissues likely also affects the total 
miRNA expression patterns. In this respect, further dissection 
of miRNA expression in distinct cell populations within skin 
or intestines could be informative. It therefore appears that 
profiling the miRNA expression pattern of peripheral blood T 
cells may not necessarily predict miRNA expression patterns 
in tissues, although possibly reflecting the miRNA profile of 
tissue-infiltrating T cells.
In conclusion, we show that the miRNA repertoire is changed 
in tissues and in T cells during aGvHD in the rat, and that there 
are wide variations in the miRNA expressed in skin, lung, or 
intestines. We also found that there was little overlap between 
miRNA expressed in intestinal T cells with those of intestinal 
tissues, indicating tissue-specific changes in miRNA in response 
to the damage evoked by T cells in aGvHD. We did, however, find 
that the differentially expressed miRNA in skin or in intestinal 
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